Loading Events

Fall Learning Event

Join us this fall for a complimentary half-day learning event and earn 2.0 CE contact hours, including 0.5 pharmacology. Learn about risk reduction strategies for patients with Acute Coronary Syndrome ensuring patients leave the hospital with optimal therapies to prevent readmission and recurrent events. You will also hear an engaging presentation from leaders in the field of inclusive health and wellness programming. Learn how to apply disability awareness and etiquette in your clinical setting.

Join the live event.

Agenda

10:30 amIntroduction and Welcome
10:40 amVASCEPA® (icosapent ethyl): Elevating the Standard of Care (non-CE)
Speaker: Joyce Ross, MSN, CRNP, CS CLS
Presented by Amarin
11:40 amSecondary Prevention in Acute Coronary Syndrome: What Nurses Need to Know (1.0 CE) Speaker: Eileen M. Handberg, PhD, ANP-BC, FACC
12:40 pmIdentifying and Managing patients with Hypertrophic Cardiomyopathy (HCM)---On the Frontlines of HCM Care (non-CE)
Speakers: Marsha McMurtry,RN, BSN and Annie Rodonski, PA-C
Presented by MyoKardia, Inc.
1:40 pmBreak
1:50 pmDisability Awareness and Etiquette in Health Promotion: Improving confidence and competence through Universal Design (1.0 CE)
Speaker: Lindsey Mullis, M.S.
2:50 pmAn Approach to Managing Lipids: Oral, Nonstatin Therapies for Lowering LDL-C (non-CE)
Presented by ESPERION Therapeutics
3:50 pmClosing

Topics

Secondary Prevention in Acute Coronary Syndrome: What Nurses Need to Know (1.0 CE)
Learning Objectives
  • Review secondary prevention guidelines for patients with acute coronary syndrome.
  • Describe non-statin therapies that may provide additional lipid lowering and risk reduction in high-risk patients hospitalized with acute coronary events.
  • Discuss a team-based approach to managing the transition of care of ACS patients from hospital to home to ensure patients receive guideline-directed care and achieve optimal health outcomes.
Disability Awareness and Etiquette in Health Promotion: Improving confidence and competence through Universal Design (1.0 CE)
Learning Objectives
  • Describe Universal Design
  • Design inclusive health promotion programming and resources utilizing universal design principles
  • Explain disability and the benefits of inclusive health promotion programming for individuals with disabilities
  • Demonstrate strategies to incorporate universal design and establish community collaborations for successful integration of individuals with disabilities 
An Approach to Managing Lipids: Oral, Nonstatin Therapies for Lowering LDL-C, Presented by ESPERION Therapeutics (non-CE)
VASCEPA® (icosapent ethyl): Elevating the Standard of Care Presented by Amarin (non-CE)
Identifying and Managing patients with Hypertrophic Cardiomyopathy (HCM)—On the Frontlines of HCM Care, Presented by Myokardia, Inc. (non-CE)

Signature Sponsor

Janssen Pharmaceuticals 

Sponsors

Esperion Therapeutics

Amarin

Myokardia, Inc.

Amgen, Inc.